Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
Abstract Background Early remdesivir administration in high-risk patients with coronavirus disease 2019 (COVID-19) is known to be effective in preventing the progression to severe disease. However, the effect of early remdesivir administration on Omicron variants, which are known to have decreased s...
Saved in:
Main Authors: | Yeon Ju La, Won Sup Oh, Changhyup Kim, Myoung-nam Lim, Yong Duk Jeon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-025-10585-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report
by: Yasunori Nagano, et al.
Published: (2025-01-01) -
Ecofriendly spectrophotometric methods for simultaneous determination of remdesivir and moxifloxacin hydrochloride as co administered drugs in corona virus treatment
by: Eman A. Madbouly, et al.
Published: (2025-01-01) -
Repetitive stability study of remdesivir/cyclodextrin complex on the international space station
by: György Dormán, et al.
Published: (2025-02-01) -
Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes
by: Dorottya Fésü, et al.
Published: (2025-01-01) -
Re-presentations to the emergency department initial presentation with COVID-19: Insights from the omicron wave
by: Daniella Audish, et al.
Published: (2025-03-01)